Molecular mechanisms of Schistosoma haematobium-associated bladder carcinogenesis and urinary biomarkers for early diagnosis: A review
PLOS Neglected Tropical Diseases · 19.11.2026 · 20 (11) · e0014868
DOI: 10.1371/journal.pntd.0014868 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 19.11.2026. Verfasst von Oumar Gaye und 6 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).
Abstract (Originalsprache)
Urogenital schistosomiasis, caused by Schistosoma haematobium , remains endemic in sub-Saharan Africa and is a major risk factor for bladder cancer, primarily squamous cell carcinoma. The molecular mechanisms of carcinogenesis are still poorly understood and diagnosis is often delayed. Thus, the objective of this review was to synthesize current knowledge on tissue and urinary biomarkers associated with S. haematobium -induced bladder cancer. This malignant transformation process is mediated by chronic inflammation, oxidative stress, genetic alterations (chromosome 9 deletions, p53, and BCL-2 mutations), and epigenetic modifications (DNA methylation). Tissue biomarkers include p53, Ki-67, COX-2, iNOS, CD117/KIT, and certain hormone receptors. Meanwhile, urinary biomarkers identified include methylation of RASSF1A, TIMP3, and RARβ; microRNAs such as MiR-71a; MAPK-3; and specific proteins and metabolites detectable by chromatography or other techniques. Available studies, mostly from Africa, are often descriptive, single-center, and small sample sizes, and experimental models mainly rely on the injection of S. haematobium eggs into mice. There is an urgent need for high-throughput sequencing and reliable, simple, and low-cost urinary biomarkers to allow early diagnosis in rural areas. Research perspectives include the development of targeted therapies, exploration of new urinary and tissue biomarkers, and strengthening international collaborations to better understand carcinogenesis and improve the management of schistosomiasis-associated bladder cancer in Africa.
Zitieren
APA
Gaye, O., Diallo, K., Fall, C. B., Compérat, E., Cussenot, O., Faye, B., & Hsieh, M. (2026). Molecular mechanisms of Schistosoma haematobium-associated bladder carcinogenesis and urinary biomarkers for early diagnosis: A review. PLOS Neglected Tropical Diseases, 20(11), e0014868. https://doi.org/10.1371/journal.pntd.0014868
Vancouver
Gaye O, Diallo K, Fall CB, Compérat E, Cussenot O, Faye B, et al. Molecular mechanisms of Schistosoma haematobium-associated bladder carcinogenesis and urinary biomarkers for early diagnosis: A review. PLOS Neglected Tropical Diseases. 2026;20(11):e0014868. doi:10.1371/journal.pntd.0014868
BibTeX
@article{Gaye2026,
author = {Gaye, Oumar and Diallo, Khadidiatou and Fall, Cheikh Bintou and Compérat, Eva and Cussenot, Olivier and Faye, Babacar and Hsieh, Michael},
title = {Molecular mechanisms of Schistosoma haematobium-associated bladder carcinogenesis and urinary biomarkers for early diagnosis: A review},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {11},
pages = {e0014868},
doi = {10.1371/journal.pntd.0014868}
}
EUVIMED